John Owen to Humans
This is a "connection" page, showing publications John Owen has written about Humans.
Connection Strength
0.244
-
Miller PJ, Farland AM, Knovich MA, Batt KM, Owen J. Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange. Am J Hematol. 2014 Jul; 89(7):695-7.
Score: 0.025
-
Knovich MA, Farland A, Owen J. Long-term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements. Eur J Haematol. 2012 Jun; 88(6):518-25.
Score: 0.022
-
Sane DC, Streer NP, Owen J. Myocardial necrosis in patients with thrombotic thrombocytopenic purpura: pathophysiology and rationale for specific therapy. Eur J Haematol. 2009 Feb; 82(2):83-92.
Score: 0.017
-
Knovich MA, Lawson HL, Burke MH, McCoy TP, Owen J. Rapid quantitative assay of ADAMTS13 activity on an automated coagulation analyzer: clinical applications and comparison with immunoblot method. Am J Hematol. 2008 Aug; 83(8):654-6.
Score: 0.017
-
Wahla AS, Ruiz J, Noureddine N, Upadhya B, Sane DC, Owen J. Myocardial infarction in thrombotic thrombocytopenic purpura: a single-center experience and literature review. Eur J Haematol. 2008 Oct; 81(4):311-6.
Score: 0.017
-
Harish VC, Zhang L, Huff JD, Lawson H, Owen J. Isolated antiplasmin deficiency presenting as a spontaneous bleeding disorder in a 63-year-old man. Blood Coagul Fibrinolysis. 2006 Nov; 17(8):673-5.
Score: 0.015
-
Owen JS, Bharadwaj MS, Thomas MJ, Bhat S, Samuel MP, Sorci-Thomas MG. Ratio determination of plasma wild-type and L159R apoA-I using mass spectrometry: tools for studying apoA-IFin. J Lipid Res. 2007 Jan; 48(1):226-34.
Score: 0.015
-
Owen JS, Baker PR, O'Flaherty JT, Thomas MJ, Samuel MP, Wooten RE, Wykle RL. Stress-induced platelet-activating factor synthesis in human neutrophils. Biochim Biophys Acta. 2005 Apr 15; 1733(2-3):120-9.
Score: 0.013
-
Owen JS, Wykle RL, Samuel MP, Thomas MJ. An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry. J Lipid Res. 2005 Feb; 46(2):373-82.
Score: 0.013
-
Keung YK, Owen J. Iron deficiency and thrombosis: literature review. Clin Appl Thromb Hemost. 2004 Oct; 10(4):387-91.
Score: 0.013
-
Knovich MA, Craver K, Matulis MD, Lawson H, Owen J. Simplified assay for VWF cleaving protease (ADAMTS13) activity and inhibitor in plasma. Am J Hematol. 2004 Jul; 76(3):286-90.
Score: 0.013
-
Nicol KK, Shelton BJ, Knovich MA, Owen J. Overweight individuals are at increased risk for thrombotic thrombocytopenic purpura. Am J Hematol. 2003 Nov; 74(3):170-4.
Score: 0.012
-
Kuhlman P, Miller P, Farland A, Owen J, Batt K. Correlating S100B with disease course in a case of new onset, acquired thrombotic thrombocytopenic purpura (TTP): Could this be a new predictive biomarker in TTP? J Clin Apher. 2018 Aug; 33(4):541-545.
Score: 0.008
-
Lewis JA, Petty WJ, Harmon M, Peacock JE, Valente K, Owen J, Pirmohamed M, Lesser GJ. Hemolytic anemia in two patients with glioblastoma multiforme: A possible interaction between vorinostat and dapsone. J Oncol Pharm Pract. 2015 Jun; 21(3):220-3.
Score: 0.006
-
Sorci-Thomas MG, Owen JS, Fulp B, Bhat S, Zhu X, Parks JS, Shah D, Jerome WG, Gerelus M, Zabalawi M, Thomas MJ. Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers. J Lipid Res. 2012 Sep; 53(9):1890-909.
Score: 0.006
-
Sorci-Thomas MG, Zabalawi M, Bharadwaj MS, Wilhelm AJ, Owen JS, Asztalos BF, Bhat S, Thomas MJ. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice. Biochim Biophys Acta. 2012 Mar; 1821(3):502-12.
Score: 0.005
-
Wilhelm AJ, Zabalawi M, Owen JS, Shah D, Grayson JM, Major AS, Bhat S, Gibbs DP, Thomas MJ, Sorci-Thomas MG. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem. 2010 Nov 12; 285(46):36158-69.
Score: 0.005
-
Wajih N, Owen J, Wallin R. Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection. Thromb Res. 2008; 122(3):405-10.
Score: 0.004
-
Huff JD, Keung YK, Thakuri M, Beaty MW, Hurd DD, Owen J, Molnár I. Copper deficiency causes reversible myelodysplasia. Am J Hematol. 2007 Jul; 82(7):625-30.
Score: 0.004
-
Wajih N, Hutson SM, Owen J, Wallin R. Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle. J Biol Chem. 2005 Sep 09; 280(36):31603-7.
Score: 0.003
-
O'Flaherty JT, Rogers LC, Chadwell BA, Owen JS, Rao A, Cramer SD, Daniel LW. 5(S)-Hydroxy-6,8,11,14-E,Z,Z,Z-eicosatetraenoate stimulates PC3 cell signaling and growth by a receptor-dependent mechanism. Cancer Res. 2002 Dec 01; 62(23):6817-9.
Score: 0.003
-
Baker PR, Owen JS, Nixon AB, Thomas L, Wooten R, Daniel LW, O'Flaherty JT, Wykle RL. Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases. Biochim Biophys Acta. 2002 Oct 21; 1592(2):175-84.
Score: 0.003
-
Herrington DM, Vittinghoff E, Howard TD, Major DA, Owen J, Reboussin DM, Bowden D, Bittner V, Simon JA, Grady D, Hulley SB. Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease. Arterioscler Thromb Vasc Biol. 2002 Jun 01; 22(6):1012-7.
Score: 0.003